NovALIX Conference – 13-15 June 2018

Calixar selected to present at the 5th NovAliX Conference “Biophysics in drug Discovery 2018.


Anass JAWHARI, CSO of CALIXAR will be attending and presenting a new published work (Scientific Reports – Nature) on adenosine receptor (A2A) entitled “Enabling NMR-Based Fragment Screening Using Stabilized Native GPCR” at the 5th NovALIX Conference in Boston in June 2018.


You are welcome to book some time to meet with Anass by contacting him directly at


About the NovAliX Conference “Biophysics in Drug Discovery”


The fifth edition of the conference intends to bring together biophysicists and medicinal chemists to improve the synergy between their disciplines in order to deliver better drugs on a shorter timeline.

The Scientific Programme will include the following sessions :


  • Membrane Proteins
  • Protein-Protein Interactions
  • Cryo-EM (Special Feature of the Conference)
  • Biotherapeutics
  • Target Engagement
  • Hot Topics
Schedule a meeting:


DATES : June 13-15, 2018

MORE INFO : 5th NovALIX Conference Target